This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Imlygic
  • /
  • Efficacy and Safety Study of Talimogene Laherparep...
Clinical trial

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Read time: 1 mins
Last updated:1st Apr 2009
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest